Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application

NCT00807924 is registered in ClinicalTrials.gov with Novian Health Inc. as lead sponsor.

NCT NCT00807924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00807924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the Long Term Safety and Efficacy of Novilase™ Breast Interstitial Laser Therapy in Real World Application
Lead sponsor
Novian Health Inc.
Phase
Observational
Overall status
Completed
Start date
December 31, 2008
Completion date
August 8, 2018
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign breast conditions; breast fibroadenomas